CBD Cos. Must Beware COVID Claims Amid Gov't Scrutiny
In March, the U.S. Food and Drug Administration, in conjunction with the Federal Trade Commission, issued seven CBD-related warning letters to businesses around the country, primarily due to health claims related...To view the full article, register now.
Already a subscriber? Click here to view full article